» Articles » PMID: 31289380

Optical Control of Neuronal Ion Channels and Receptors

Overview
Specialty Neurology
Date 2019 Jul 11
PMID 31289380
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Light-controllable tools provide powerful means to manipulate and interrogate brain function with relatively low invasiveness and high spatiotemporal precision. Although optogenetic approaches permit neuronal excitation or inhibition at the network level, other technologies, such as optopharmacology (also known as photopharmacology) have emerged that provide molecular-level control by endowing light sensitivity to endogenous biomolecules. In this Review, we discuss the challenges and opportunities of photocontrolling native neuronal signalling pathways, focusing on ion channels and neurotransmitter receptors. We describe existing strategies for rendering receptors and channels light sensitive and provide an overview of the neuroscientific insights gained from such approaches. At the crossroads of chemistry, protein engineering and neuroscience, optopharmacology offers great potential for understanding the molecular basis of brain function and behaviour, with promises for future therapeutics.

Citing Articles

Recent Progress in Regulating the Activity of Enzymes with Photoswitchable Inhibitors.

Chen Y Molecules. 2024; 29(19).

PMID: 39407453 PMC: 11477607. DOI: 10.3390/molecules29194523.


Reversible Control of Native GluN2B-Containing NMDA Receptors with Visible Light.

Geoffroy C, Berraud-Pache R, Cheron N, McCort-Tranchepain I, Doria J, Paoletti P ACS Chem Neurosci. 2024; 15(18):3321-3343.

PMID: 39242213 PMC: 11413854. DOI: 10.1021/acschemneuro.4c00247.


Applications of pyroptosis activators in tumor immunotherapy.

Bao X, Sun M, Meng L, Zhang H, Yi X, Zhang P Mater Today Bio. 2024; 28:101191.

PMID: 39221221 PMC: 11363858. DOI: 10.1016/j.mtbio.2024.101191.


Optogenetic Brain-Computer Interfaces.

Tang F, Yan F, Zhong Y, Li J, Gong H, Li X Bioengineering (Basel). 2024; 11(8).

PMID: 39199779 PMC: 11351350. DOI: 10.3390/bioengineering11080821.


Emerging optogenetics technologies in biomedical applications.

Ren H, Cheng Y, Wen G, Wang J, Zhou M Smart Med. 2024; 2(4):e20230026.

PMID: 39188295 PMC: 11235740. DOI: 10.1002/SMMD.20230026.


References
1.
Lemoine D, Jiang R, Taly A, Chataigneau T, Specht A, Grutter T . Ligand-gated ion channels: new insights into neurological disorders and ligand recognition. Chem Rev. 2012; 112(12):6285-318. DOI: 10.1021/cr3000829. View

2.
Smart T, Paoletti P . Synaptic neurotransmitter-gated receptors. Cold Spring Harb Perspect Biol. 2012; 4(3). PMC: 3282413. DOI: 10.1101/cshperspect.a009662. View

3.
Foster D, Conn P . Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders. Neuron. 2017; 94(3):431-446. PMC: 5482176. DOI: 10.1016/j.neuron.2017.03.016. View

4.
Rask-Andersen M, Almen M, Schioth H . Trends in the exploitation of novel drug targets. Nat Rev Drug Discov. 2011; 10(8):579-90. DOI: 10.1038/nrd3478. View

5.
Coetzee W, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T . Molecular diversity of K+ channels. Ann N Y Acad Sci. 1999; 868:233-85. DOI: 10.1111/j.1749-6632.1999.tb11293.x. View